title: Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients.
abstract: The fibroblast growth factor receptor (FGFR) family plays important roles in regulating cell growth, proliferation, survival, differentiation and angiogenesis. Deregulation of the FGF/FGFR signaling pathway has been associated with multiple development syndromes and cancers, and thus therapeutic strategies targeting FGFs and FGFR in human cancer are currently being explored. However, few studies on the FGF/FGFR pathway have been conducted in sarcoma, which has a poor outcome with traditional treatments such as surgery, chemotherapy, and radiotherapy. Hence, in the present review, we provide an overview of the role of the FGF/FGFR pathway signal in sarcoma and FGFR inhibitors, which might be new targets for the treatment of sarcomas according to recent research.
authors.affiliation: Department of Bone and Soft Tissue Tumor.
authors.forename: Wen-Ya
authors.initials: WY
authors.lastname: Zhou
authors.affiliation: Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
authors.forename: Hong
authors.initials: H
authors.lastname: Zheng
authors.affiliation: Department of Diagnostics, Tianjin Medical University, Tianjin 300061, China.
authors.forename: Xiao-Ling
authors.initials: XL
authors.lastname: Du
authors.affiliation: Department of Bone and Soft Tissue Tumor.
authors.forename: Ji-Long
authors.initials: JL
authors.lastname: Yang
keywords: FGFR inhibitors; FGFR signaling pathway; Sarcoma